Previous close | 173.78 |
Open | 173.76 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 171.53 - 173.76 |
52-week range | 110.74 - 186.03 |
Volume | |
Avg. volume | 109,025 |
Market cap | 5.581B |
Beta (5Y monthly) | 0.64 |
PE ratio (TTM) | 47.79 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.79 (0.45%) |
Ex-dividend date | 26 Dec 2023 |
1y target est | N/A |
MONTVALE, N.J., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, October 25, 2024, at 11:00 AM Eastern Time (ET) to review third quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Third quarter results will be published prior to the market opening on Friday, October 25, 2024. The press release, and its accompanying financial exhibits, will also be
MONTVALE, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balche
MONTVALE, N.J., July 26, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal second quarter ended June 30, 2024. The Company reported quarterly net sales of $234.1 million, quarterly net earnings of $32.1 million, adjusted EBITDA(a) of $62.3 million, and free cash flow(a) of $38.4 million. Ted Harris, Chairman, President and CEO of Balchem said, "We delivered solid second quarter financials with record earnings from operations and adju